Insulet (PODD) Share-based Compensation (2016 - 2026)
Insulet filings provide 16 years of Share-based Compensation readings, the most recent being $20.3 million for Q4 2025.
- On a quarterly basis, Share-based Compensation rose 1.5% to $20.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $62.7 million, a 9.52% decrease, with the full-year FY2025 number at $62.7 million, down 9.52% from a year prior.
- Share-based Compensation hit $20.3 million in Q4 2025 for Insulet, up from $16.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $20.3 million in Q4 2025 to a low of $7.5 million in Q2 2025.
- Median Share-based Compensation over the past 5 years was $11.6 million (2022), compared with a mean of $12.8 million.
- Biggest five-year swings in Share-based Compensation: skyrocketed 72.38% in 2024 and later plummeted 55.88% in 2025.
- Insulet's Share-based Compensation stood at $8.6 million in 2021, then skyrocketed by 30.23% to $11.2 million in 2022, then rose by 13.39% to $12.7 million in 2023, then skyrocketed by 57.48% to $20.0 million in 2024, then rose by 1.5% to $20.3 million in 2025.
- The last three reported values for Share-based Compensation were $20.3 million (Q4 2025), $16.7 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.